BRYNN MCKEON: Open Payments
NPI 1669929899 · MONTICELLO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 32 payments from 9 companies in 2025. Trend: 2023 $615 · 2024 $927 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $252 |
| ABBVIE INC. | 6 | $138 |
| Novo Nordisk Inc | 2 | $52 |
| PFIZER INC. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Lilly USA, LLC | 1 | $22 |
| Amgen Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $21 |
Products named: BREZTRI, UBRELVY, QULIPTA, REXULTI, FARXIGA, NURTEC ODT, Wegovy, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
